Temp-controlled radiofrequency tech developer Thermi said this week that the FDA granted it a notice of completion following an inquiry on products used in "vaginal rejuvenation" procedures. Irving, Texas-based Thermi received a notice from the FDA on July 24 regarding specific claims about the company's ThermiVa device. The ThermiVa is a non-ablative RF device cleared [...]The post FDA clears Thermi in "vaginal rejuvenation" product inquiry appeared first on MassDevice.